Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.23M Buy
17,852
+1,112
+7% +$221K 0.02% 700
2025
Q4
$3.62M Buy
16,740
+2,290
+16% +$501K 0.02% 614
2025
Q3
$3.7M Buy
14,450
+1,482
+11% +$372K 0.02% 515
2025
Q2
$3.36M Buy
12,968
+2,743
+27% +$698K 0.03% 476
2025
Q1
$2.46M Buy
10,225
+1,332
+15% +$335K 0.03% 470
2024
Q4
$2.26M Buy
8,893
+1,793
+25% +$480K 0.03% 463
2024
Q3
$2.08M Buy
7,100
+2,914
+70% +$822K 0.04% 358
2024
Q2
$1.01M Buy
4,186
+2,889
+223% +$689K 0.04% 349
2024
Q1
$347K Buy
1,297
+197
+18% +$50.1K 0.05% 337
2023
Q4
$272K Hold
1,100
0.07% 226
2023
Q3
$201K Hold
1,100
0.09% 164
2023
Q2
$259K Hold
1,100
0.12% 143
2023
Q1
$223K Hold
1,100
0.11% 151
2022
Q4
$214K Buy
+1,100
New +$201K 0.11% 161
2022
Q3
Sell
-1,100
Closed -$201K 189
2022
Q2
$201K Hold
1,100
0.12% 168
2022
Q1
$261K Hold
1,100
0.15% 144
2021
Q4
$322K Hold
1,100
0.19% 117
2021
Q3
$279K Hold
1,100
0.18% 128
2021
Q2
$263K Sell
1,100
-100
-8% -$22.3K 0.17% 136
2021
Q1
$217K Buy
1,200
+100
+9% +$17.7K 0.16% 142
2020
Q4
$212K Buy
+1,100
New +$185K 0.18% 128

Other funds holding EFX

&Partners's EFX Position: Q1 2026 in Review

&Partners increased its Equifax (EFX) stake by 6.6% in Q1 2026, buying an estimated $221K and bringing the position to 17,852 shares worth $3.23M. The position accounts for 0.02% of the portfolio, ranked #700.

&Partners first reported a position in EFX in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.7M in Q3 2025. 870 funds tracked by Wall St. Rank hold EFX as of Q1 2026.

  • &Partners held 17,852 shares of Equifax worth $3.23M as of Q1 2026.
  • &Partners bought 1,112 Equifax shares in Q1 2026, an estimated $221K.
  • Equifax made up 0.02% of &Partners's portfolio in Q1 2026, its #700 holding.
  • &Partners first reported a position in Equifax in Q4 2020 and has held it in 21 quarters since.
  • &Partners's Equifax position peaked at $3.7M in Q3 2025.
  • 870 funds tracked by Wall St. Rank held Equifax as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.